The UK was third in the world for healthtech investment raised in 2020 at $2.3bn, behind only the United States ($38.6bn) and China ($12.2bn). Healthtech investment was second only to Fintech in 2020, making up just under 12% of all investment into UK tech firms.

According to Tech Nation, there are just over 3,000 startups and scaleups operating in healthtech in the UK, of which around 400 have recorded high growth over the past two years (20% year on year growth).

Flashfuture is able to provide services to both the Investor community (VCs and PE houses) and those seeking investment to grow their businesses.

Services for Investors

Staff at Flashfuture have performed due diligence reviews of organisations, sometimes for acquisition purposes, and also for those seeking to invest. We understand the health tech market, the competitive landscape, and the opportunities for new and growing players in that market. We can provide light touch reviews and reports, or more extensive investigations into performance and likely growth. Investors may ask us to take a NED role on the Board once they have invested, to safeguard their investment and report back on company activities that may impact it - either positively or negatively.

Services for those seeking investment

A number of our clients have started to ask us to help them prepare pitches for investment; analysing their business model, the market they operate in, creating realistic growth models and then developing the resultant financial modelling. We do this in partnership with founders and their teams, and can show demonstrable success already.